Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $42 | In Stock | |
5 mg | $99 | In Stock | |
10 mg | $157 | In Stock | |
25 mg | $260 | In Stock | |
50 mg | $400 | In Stock | |
1 mL x 10 mM (in DMSO) | $99 | In Stock |
Description | Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia. |
Targets&IC50 | PH2:0.029 μM, FIH (factor inhibiting HIF):29 μM |
Alias | PG-1016548, AKB-6548 |
Molecular Weight | 306.7 |
Formula | C14H11ClN2O4 |
Cas No. | 1000025-07-9 |
Smiles | OC(=O)CNC(=O)c1ncc(cc1O)-c1cccc(Cl)c1 |
Relative Density. | 1.461 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 100 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.